143 related articles for article (PubMed ID: 15239000)
1. A comparative analysis of phenothiazinium salts for the photosensitisation of murine fibrosarcoma (RIF-1) cells in vitro.
Walker I; Gorman SA; Cox RD; Vernon DI; Griffiths J; Brown SB
Photochem Photobiol Sci; 2004 Jul; 3(7):653-9. PubMed ID: 15239000
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives.
MacDonald IJ; Morgan J; Bellnier DA; Paszkiewicz GM; Whitaker JE; Litchfield DJ; Dougherty TJ
Photochem Photobiol; 1999 Nov; 70(5):789-97. PubMed ID: 10568171
[TBL] [Abstract][Full Text] [Related]
3. Fluence rate as a modulator of PDT mechanisms.
Henderson BW; Busch TM; Snyder JW
Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
5. Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.
Mir Y; van Lier JE; Paquette B; Houde D
Photochem Photobiol; 2008; 84(5):1182-6. PubMed ID: 18331397
[TBL] [Abstract][Full Text] [Related]
6. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
7. In vitro photodynamic inactivation of Candida species and mouse fibroblasts with phenothiazinium photosensitisers and red light.
Rodrigues GB; Dias-Baruffi M; Holman N; Wainwright M; Braga GU
Photodiagnosis Photodyn Ther; 2013 May; 10(2):141-9. PubMed ID: 23769280
[TBL] [Abstract][Full Text] [Related]
8. Phenothiazinium-based photobactericidal materials.
Wainwright M; Byrne MN; Gattrell MA
J Photochem Photobiol B; 2006 Sep; 84(3):227-30. PubMed ID: 16713280
[TBL] [Abstract][Full Text] [Related]
9. In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a.
Gryshuk AL; Chen Y; Potter W; Ohulchansky T; Oseroff A; Pandey RK
J Med Chem; 2006 Mar; 49(6):1874-81. PubMed ID: 16539373
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a photostable near-infrared-absorbing photosensitizer for selective photodamage to cancer cells.
Hsieh TS; Wu JY; Chang CC
Chemistry; 2014 Jul; 20(31):9709-15. PubMed ID: 24990530
[TBL] [Abstract][Full Text] [Related]
11. Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.
Bobrov N; Cavarga I; Longauer F; Rybárová S; Fedorocko P; Brezáni P; Miskovský P; Mirossay L; Stubna J
Phytomedicine; 2007 Feb; 14(2-3):172-8. PubMed ID: 17095201
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, comparative photosensitizing efficacy, human serum albumin (site II) binding ability, and intracellular localization characteristics of novel benzobacteriochlorins derived from vic-dihydroxybacteriochlorins.
Li G; Graham A; Chen Y; Dobhal MP; Morgan J; Zheng G; Kozyrev A; Oseroff A; Dougherty TJ; Pandey RK
J Med Chem; 2003 Dec; 46(25):5349-59. PubMed ID: 14640543
[TBL] [Abstract][Full Text] [Related]
13. Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
Wang HW; Rickter E; Yuan M; Wileyto EP; Glatstein E; Yodh A; Busch TM
Photochem Photobiol; 2007; 83(5):1040-8. PubMed ID: 17880498
[TBL] [Abstract][Full Text] [Related]
14. In vitro demonstration of the heavy-atom effect for photodynamic therapy.
Gorman A; Killoran J; O'Shea C; Kenna T; Gallagher WM; O'Shea DF
J Am Chem Soc; 2004 Sep; 126(34):10619-31. PubMed ID: 15327320
[TBL] [Abstract][Full Text] [Related]
15. The effects of ultrasound and light on indocyanine-green-treated tumour cells and tissues.
Nomikou N; Sterrett C; Arthur C; McCaughan B; Callan JF; McHale AP
ChemMedChem; 2012 Aug; 7(8):1465-71. PubMed ID: 22715137
[TBL] [Abstract][Full Text] [Related]
16. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
Khdair A; Gerard B; Handa H; Mao G; Shekhar MP; Panyam J
Mol Pharm; 2008; 5(5):795-807. PubMed ID: 18646775
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro photodynamic studies with benzochlorin iminium salts delivered by a lipid emulsion.
Garbo GM; Fingar VH; Wieman TJ; Noakes EB; Haydon PS; Cerrito PB; Kessel DH; Morgan AR
Photochem Photobiol; 1998 Oct; 68(4):561-8. PubMed ID: 9796439
[TBL] [Abstract][Full Text] [Related]
18. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
19. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
